This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Tumor necrosis factor receptor
From Proteopedia
(Difference between revisions)
| Line 12: | Line 12: | ||
* '''TNFRSF 10''' see [[TRAIL]];<br /> | * '''TNFRSF 10''' see [[TRAIL]];<br /> | ||
* '''TNFRSF 10B''' is called '''Dr5''';<br /> | * '''TNFRSF 10B''' is called '''Dr5''';<br /> | ||
| - | * '''TNFRSF 11''' is called '''RANKL''';<br /> | ||
* '''TNFRSF 11A''' is called '''RANK''';<br /> | * '''TNFRSF 11A''' is called '''RANK''';<br /> | ||
* '''TNFRSF 11B''' is called '''Osteoprotegerin''';<br /> | * '''TNFRSF 11B''' is called '''Osteoprotegerin''';<br /> | ||
* '''TNFRSF 12''' is called '''TWEAK''';<br /> | * '''TNFRSF 12''' is called '''TWEAK''';<br /> | ||
* '''TNFRSF 12A''' is called '''TWEAKR''';<br /> | * '''TNFRSF 12A''' is called '''TWEAKR''';<br /> | ||
| - | * '''TNFRSF 13''' is called '''APRIL''';<br /> | ||
* '''TNFRSF 13B''' is called '''BAFF or sTALL-1''';<br /> | * '''TNFRSF 13B''' is called '''BAFF or sTALL-1''';<br /> | ||
* '''TNFRSF 13C''' is called '''BAFF receptor''';<br /> | * '''TNFRSF 13C''' is called '''BAFF receptor''';<br /> | ||
| Line 67: | Line 65: | ||
**[[1aly]] – hTNFSF-5 extracellular domain <BR /> | **[[1aly]] – hTNFSF-5 extracellular domain <BR /> | ||
| - | **[[1i9r]], [[5dmi]], [[ | + | **[[1i9r]], [[5dmi]], [[5ihl]] – hTNFSF-5 extracellular domain + antibody<BR /> |
| - | **[[3lkj]] – hTNFSF-5 extracellular domain + inhibitor<BR /> | + | **[[5dmj]] – hTNFRSF-5 extracellular domain (mutant) + antibody<br /> |
| + | **[[3lkj]], [[5ihl]] – hTNFSF-5 extracellular domain + inhibitor<BR /> | ||
**[[3qd6]] – hTNFRSF-5 extracellular domain + CD40 ligand<br /> | **[[3qd6]] – hTNFRSF-5 extracellular domain + CD40 ligand<br /> | ||
| Line 97: | Line 96: | ||
**[[4n90]] – hTNFRSF-10B + hTNFRSF-10 + antibody <br /> | **[[4n90]] – hTNFRSF-10B + hTNFRSF-10 + antibody <br /> | ||
| - | *Tumor necrosis factor receptor superfamily-11 | + | *Tumor necrosis factor receptor superfamily-11 |
**[[1jtz]], [[1iqa]], [[1s55]] – mTNFSF-11 receptor-binding domain<BR /> | **[[1jtz]], [[1iqa]], [[1s55]] – mTNFSF-11 receptor-binding domain<BR /> | ||
**[[3me2]], [[3qbq]], [[4giq]] – mTNFSF-11 receptor-binding domain + RANK <BR /> | **[[3me2]], [[3qbq]], [[4giq]] – mTNFSF-11 receptor-binding domain + RANK <BR /> | ||
| - | **[[4e4d]] – mTNFSF-11 receptor-binding domain + osteoprotegerin<BR /> | ||
| - | **[[3urf]] – hTNFSF-11 receptor-binding domain + osteoprotegerin<BR /> | ||
*Tumor necrosis factor receptor superfamily-11A (RANK) | *Tumor necrosis factor receptor superfamily-11A (RANK) | ||
| Line 111: | Line 108: | ||
*Tumor necrosis factor receptor superfamily-11B (Osteoprotegerin) | *Tumor necrosis factor receptor superfamily-11B (Osteoprotegerin) | ||
| - | **[[3urf]] – hTNFRSF-11B extracellular domain + | + | **[[3urf]] – hTNFRSF-11B extracellular domain + RANKL<br /> |
| - | **[[4e4d]] – mTNFRSF-11B extracellular domain + | + | **[[4e4d]] – mTNFRSF-11B extracellular domain + RANKL<br /> |
*TNFSF-12 superfamily member 12 (TWEAK) | *TNFSF-12 superfamily member 12 (TWEAK) | ||
| Line 121: | Line 118: | ||
**[[2rpj]], [[2kmz]], [[2epq]] – hTNFRSF-12A cysteine-rich domain – NMR <br /> | **[[2rpj]], [[2kmz]], [[2epq]] – hTNFRSF-12A cysteine-rich domain – NMR <br /> | ||
| - | |||
| - | *TNFSF-13 superfamily member 13 (APRIL) | ||
| - | |||
| - | **[[1u5x]], [[1u5y]], [[1u5z]] – mTNFSF-13 extracellular domain <BR /> | ||
| - | **[[1xu1]] – mTNFSF-13 extracellular domain + TNFSF-13B <BR /> | ||
| - | **[[1xu2]] – mTNFSF-13 extracellular domain + BCMA <BR /> | ||
| - | **[[3k48]] – mTNFSF-13 extracellular domain + peptide<BR /> | ||
| - | **[[4zch]] – hTNFSF-13 extracellular domain + TNFSF-13B <BR /> | ||
*TNFSF-13B superfamily member 13B (BAFF, sTALL-1) | *TNFSF-13B superfamily member 13B (BAFF, sTALL-1) | ||
| Line 137: | Line 126: | ||
**[[4v46]] – hTNFSF-13B extracellular domain + hTNFRSF-13C + BAFF<BR /> | **[[4v46]] – hTNFSF-13B extracellular domain + hTNFRSF-13C + BAFF<BR /> | ||
**[[1osg]], [[3v56]] – hTNFSF-13B extracellular domain + hTNFRSF-13C peptide <BR /> | **[[1osg]], [[3v56]] – hTNFSF-13B extracellular domain + hTNFRSF-13C peptide <BR /> | ||
| + | **[[1xu1]] – hTNFRSF-13B extracellular domain + APRIL <br /> | ||
*Tumor necrosis factor receptor superfamily-13C (BAFF receptor) | *Tumor necrosis factor receptor superfamily-13C (BAFF receptor) | ||
**[[1osx]] – hTNFRSF-13C extracellular domain - NMR <br /> | **[[1osx]] – hTNFRSF-13C extracellular domain - NMR <br /> | ||
| - | **[[2hfg]] – | + | **[[2hfg]] – hTNFRSF-13C cysteine-rich domain + antibody<BR /> |
*Tumor necrosis factor receptor superfamily-14 (LIGHT) | *Tumor necrosis factor receptor superfamily-14 (LIGHT) | ||
| Line 165: | Line 155: | ||
**[[2kn1]] – hTNFRSF-17 extracellular domain - NMR <br /> | **[[2kn1]] – hTNFRSF-17 extracellular domain - NMR <br /> | ||
**[[4zfo]] – hTNFRSF-17 extracellular domain + antibody <br /> | **[[4zfo]] – hTNFRSF-17 extracellular domain + antibody <br /> | ||
| + | **[[1xu2]] – hTNFRSF-17 extracellular domain + APRIL <br /> | ||
*Tumor necrosis factor receptor superfamily-18 (GITRL) | *Tumor necrosis factor receptor superfamily-18 (GITRL) | ||
Revision as of 22:07, 12 October 2017
| |||||||||||
3D structures of tumor necrosis factor receptor
Updated on 12-October-2017
References
- ↑ Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol. 1999;17:331-67. PMID:10358762 doi:http://dx.doi.org/10.1146/annurev.immunol.17.1.331
- ↑ Lopalco G, Rigante D, Vitale A, Frediani B, Iannone F, Cantarini L. Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate. Clin Rheumatol. 2015 Apr;34(4):807-9. doi: 10.1007/s10067-014-2556-8. Epub 2014, Mar 11. PMID:24609716 doi:http://dx.doi.org/10.1007/s10067-014-2556-8
- ↑ Naismith JH, Devine TQ, Kohno T, Sprang SR. Structures of the extracellular domain of the type I tumor necrosis factor receptor. Structure. 1996 Nov 15;4(11):1251-62. PMID:8939750
